Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide.
Endotoxin-stimulated monocytes can elicit a dual procoagulant response. They express tissue factor and expose phosphatidylserine in the outer leaflet of the plasma membrane. Tissue factor, a membrane glycoprotein, is the cellular trigger of blood coagulation reactions. Phosphatidylserine is an essential anionic phospholipid for surface amplification of thrombin generation. In this study the distribution of these two procoagulant entities between activated monocytes and derived microparticles was assessed after stimulation by LPS. The presence of CD14, CD11a, and CD18, and possible associated adhesion potential were examined, particularly on microparticles. Tissue factor was evidenced by using a specific functional assay and flow cytometry. Phosphatidylserine exposure was monitored through its catalytic activity in a thrombin generation assay and by flow cytometry with the use of FITC-conjugated annexin V, a protein probe of anionic phospholipids. CD14, CD11a, and CD18 were detected by flow cytometry. The interaction of microparticle CD11a/CD18 with intracellular adhesion molecule-1 was demonstrated by using immobilized recombinant intracellular adhesion molecule-1 fusion protein. The major part of tissue factor and phosphatidylserine-dependent procoagulant activity was associated with microparticles after LPS stimulation. This was confirmed by flow cytometry. The presence of functional CD11a/CD18, and CD14 on microparticles testifies to an associated adhesion potential. These results show that membrane vesiculation could be responsible for dissemination of inducible monocyte procoagulant activities and suggest that derived microparticles could also participate in endothelium stimulation. This emphasizes the role of monocyte as a central element in the coupling between inflammation/infection and thrombosis.
Satta
N
N
Thrombosis and Autoimmunity Group, Medical Faculty, Louis Pasteur University, Strasbourg, France.
Toti
F
F
Feugeas
O
O
Bohbot
A
A
Dachary-Prigent
J
J
Eschwège
V
V
Hedman
H
H
Freyssinet
J M
JM
D017304:Annexin A5 / Q000378:metabolism; D015703:Antigens, CD / Q000378:metabolism; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism; D001779:Blood Coagulation Factors / Q000378:metabolism*; D003994:Bucladesine / Q000494:pharmacology; D018821:CD18 Antigens; D015815:Cell Adhesion Molecules / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D006801:Humans; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides / Q000494:pharmacology; D016169:Lymphocyte Function-Associated Antigen-1 / Q000378:metabolism; D009000:Monocytes / Q000648:ultrastructure*; D010718:Phosphatidylserines / Q000378:metabolism; D013925:Thromboplastin / Q000378:metabolism*
D017304:Annexin A5; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D001779:Blood Coagulation Factors; D018821:CD18 Antigens; D015815:Cell Adhesion Molecules; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D016169:Lymphocyte Function-Associated Antigen-1; D010718:Phosphatidylserines; C045071:leukocyte procoagulant activity; D003609:Dactinomycin; D003994:Bucladesine; D013925:Thromboplastin